Literature DB >> 26474664

Structure activity relationships of benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.

Jihyae Ann1, Aeran Jung1, Mi-Yeon Kim1, Hyuk-Min Kim1, HyungChul Ryu2, Sunjoo Kim2, Dong Wook Kang3, Sunhye Hong4, Minghua Cui4, Sun Choi4, Peter M Blumberg5, Robert Frank-Foltyn6, Gregor Bahrenberg6, Hannelore Stockhausen6, Thomas Christoph6, Jeewoo Lee7.   

Abstract

A series of 2-substituted 4-(trifluoromethyl)benzyl C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides were investigated for hTRPV1 antagonism. The analysis indicated that the phenyl C-region derivatives exhibited better antagonism than those of the corresponding pyridine surrogates for most of the series examined. Among the phenyl C-region derivatives, the two best compounds 43 and 44S antagonized capsaicin selectively relative to their antagonism of other activators and showed excellent potencies with K(i(CAP))=0.3 nM. These two compounds blocked capsaicin-induced hypothermia, consistent with TRPV1 as their site of action, and they demonstrated promising analgesic activities in a neuropathic pain model without hyperthermia. The docking study of 44S in our hTRPV1 homology model indicated that its binding mode was similar with that of its pyridine surrogate in the A- and B-regions but displayed a flipped configuration in the C-region.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Analgesic; TRPV1 antagonists; Vanilloid receptor 1

Mesh:

Substances:

Year:  2015        PMID: 26474664      PMCID: PMC6959537          DOI: 10.1016/j.bmc.2015.10.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  25 in total

Review 1.  Vanilloid (Capsaicin) receptors and mechanisms.

Authors:  A Szallasi; P M Blumberg
Journal:  Pharmacol Rev       Date:  1999-06       Impact factor: 25.468

Review 2.  Transient receptor potential vanilloid type 1 antagonists: a patent review (2011 - 2014).

Authors:  Yoonji Lee; Sunhye Hong; Minghua Cui; Pankaz K Sharma; Jeewoo Lee; Sun Choi
Journal:  Expert Opin Ther Pat       Date:  2015-03       Impact factor: 6.674

3.  Analgesic potential of TRPV1 antagonists.

Authors:  Philip R Kym; Michael E Kort; Charles W Hutchins
Journal:  Biochem Pharmacol       Date:  2009-03-05       Impact factor: 5.858

Review 4.  Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: Recent advances and setbacks.

Authors:  Gilbert Y Wong; Narender R Gavva
Journal:  Brain Res Rev       Date:  2008-12-25

Review 5.  Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions.

Authors:  Luciano De Petrocellis; Aniello S Moriello
Journal:  Recent Pat CNS Drug Discov       Date:  2013-12

6.  The cloned capsaicin receptor integrates multiple pain-producing stimuli.

Authors:  M Tominaga; M J Caterina; A B Malmberg; T A Rosen; H Gilbert; K Skinner; B E Raumann; A I Basbaum; D Julius
Journal:  Neuron       Date:  1998-09       Impact factor: 17.173

Review 7.  Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature.

Authors:  Eric A Voight; Michael E Kort
Journal:  Expert Opin Ther Pat       Date:  2010-09       Impact factor: 6.674

Review 8.  Multisteric TRPV1 nocisensor: a target for analgesics.

Authors:  János Szolcsányi; Zoltán Sándor
Journal:  Trends Pharmacol Sci       Date:  2012-10-12       Impact factor: 14.819

Review 9.  Clinical development of TRPV1 antagonists: targeting a pivotal point in the pain pathway.

Authors:  Martin J Gunthorpe; Boris A Chizh
Journal:  Drug Discov Today       Date:  2008-12-26       Impact factor: 7.851

10.  Contributions of different modes of TRPV1 activation to TRPV1 antagonist-induced hyperthermia.

Authors:  Andras Garami; Yury P Shimansky; Eszter Pakai; Daniela L Oliveira; Narender R Gavva; Andrej A Romanovsky
Journal:  J Neurosci       Date:  2010-01-27       Impact factor: 6.167

View more
  4 in total

1.  t-Butyl pyridine and phenyl C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Sunho Lee; Dong Wook Kang; HyungChul Ryu; Changhoon Kim; Jihyae Ann; Hobin Lee; Eunhye Kim; Sunhye Hong; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2017-03-06       Impact factor: 3.641

2.  Pyrazole C-region analogues of 2-(3-fluoro-4-methylsulfonylaminophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Sunho Lee; Changhoon Kim; Jihyae Ann; Shivaji A Thorat; Eunhye Kim; Jongmi Park; Sun Choi; Peter M Blumberg; Robert Frank-Foltyn; Gregor Bahrenberg; Hannelore Stockhausen; Thomas Christoph; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2017-08-12       Impact factor: 2.823

3.  2-Sulfonamidopyridine C-region analogs of 2-(3-fluoro-4-methylsulfonamidophenyl)propanamides as potent TRPV1 antagonists.

Authors:  Jihyae Ann; Yooran Ki; Suyoung Yoon; Myeong Seop Kim; Jung-Un Lee; Changhoon Kim; Sunho Lee; Aeran Jung; Jisoo Baek; Sunhye Hong; Sun Choi; Larry V Pearce; Timothy E Esch; Noe A Turcios; Nancy E Lewin; Adebowale E Ogunjirin; Brienna K A Herold; Anna K McCall; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem       Date:  2016-01-28       Impact factor: 3.641

4.  Discovery of N-(3-fluoro-4-methylsulfonamidomethylphenyl)urea as a potent TRPV1 antagonistic template.

Authors:  Jihyae Ann; Wei Sun; Xing Zhou; Aeran Jung; Jisoo Baek; Sunho Lee; Changhoon Kim; Suyoung Yoon; Sunhye Hong; Sun Choi; Noe A Turcios; Brienna K A Herold; Timothy E Esch; Nancy E Lewin; Adelle Abramovitz; Larry V Pearce; Peter M Blumberg; Jeewoo Lee
Journal:  Bioorg Med Chem Lett       Date:  2016-06-07       Impact factor: 2.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.